These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12911593)

  • 1. Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII.
    Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
    J Thromb Haemost; 2003 Aug; 1(8):1777-84. PubMed ID: 12911593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope repertoire of human CD4(+) T cells on the A3 domain of coagulation factor VIII.
    Reding MT; Okita DK; Diethelm-Okita BM; Anderson TA; Conti-Fine BM
    J Thromb Haemost; 2004 Aug; 2(8):1385-94. PubMed ID: 15304045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of the A2 domain of coagulation factor VIII in hemophilia patients and healthy subjects.
    Hu GL; Okita DK; Conti-Fine BM
    J Thromb Haemost; 2004 Nov; 2(11):1908-17. PubMed ID: 15550021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects.
    Reding MT; Wu H; Krampf M; Okita DK; Diethelm-Okita BM; Christie BA; Key NS; Conti-Fine BM
    Thromb Haemost; 2000 Oct; 84(4):643-52. PubMed ID: 11057864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
    Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
    Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell responses over time in a mild hemophilia A inhibitor subject: epitope identification and transient immunogenicity of the corresponding self-peptide.
    James EA; Kwok WW; Ettinger RA; Thompson AR; Pratt KP
    J Thromb Haemost; 2007 Dec; 5(12):2399-407. PubMed ID: 18034765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site.
    Pratt KP; Qian J; Ellaban E; Okita DK; Diethelm-Okita BM; Conti-Fine B; Scott DW
    Thromb Haemost; 2004 Sep; 92(3):522-8. PubMed ID: 15351848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
    Jones TD; Phillips WJ; Smith BJ; Bamford CA; Nayee PD; Baglin TP; Gaston JS; Baker MP
    J Thromb Haemost; 2005 May; 3(5):991-1000. PubMed ID: 15869596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition of coagulation factor VIII by CD4+ T cells of healthy humans.
    Hu GL; Okita DK; Diethelm-Okita BM; Conti-Fine BM
    J Thromb Haemost; 2003 Oct; 1(10):2159-66. PubMed ID: 14521599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.
    Ettinger RA; Liberman JA; Gunasekera D; Puranik K; James EA; Thompson AR; Pratt KP
    Blood Adv; 2018 Feb; 2(4):309-322. PubMed ID: 29444872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemophilia A subjects with an intron-22 gene inversion mutation show CD4
    Gunasekera D; Vir P; Karim AF; Ragni MV; Pratt KP
    Front Immunol; 2023; 14():1128641. PubMed ID: 36936969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells from hemophilia A subjects recognize the same HLA-restricted FVIII epitope with a narrow TCR repertoire.
    Ettinger RA; Paz P; James EA; Gunasekera D; Aswad F; Thompson AR; Matthews DC; Pratt KP
    Blood; 2016 Oct; 128(16):2043-2054. PubMed ID: 27471234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The self-reactive FVIII T cell repertoire in healthy individuals relies on a short set of epitopes and public clonotypes.
    Porcheddu V; Lhomme G; Giraudet R; Correia E; Maillère B
    Front Immunol; 2024; 15():1345195. PubMed ID: 38510258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hunting down factor VIII in the immunopeptidome.
    Hartholt RB; Peyron I; Voorberg J
    Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell and T-cell epitopes in anti-factor VIII immune responses.
    Pratt KP; Thompson AR
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):80-95. PubMed ID: 19184559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
    Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
    Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the ortholog approach for hemophilia treatment complicated by factor VIII inhibitors.
    Zakas PM; Vanijcharoenkarn K; Markovitz RC; Meeks SL; Doering CB
    J Thromb Haemost; 2015 Jan; 13(1):72-81. PubMed ID: 25315236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production by CD4+ T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients.
    Hu G; Guo D; Key NS; Conti-Fine BM
    Thromb Haemost; 2007 May; 97(5):788-94. PubMed ID: 17479189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild hemophilia A patient with novel Pro1809Leu mutation develops an anti-C2 antibody inhibiting allogeneic but not autologous factor VIII activity.
    Yada K; Nogami K; Takeyama M; Ogiwara K; Wakabayashi H; Shima M
    J Thromb Haemost; 2015 Oct; 13(10):1843-53. PubMed ID: 26278069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
    Jacquemin M; Vantomme V; Buhot C; Lavend'homme R; Burny W; Demotte N; Chaux P; Peerlinck K; Vermylen J; Maillere B; van der Bruggen P; Saint-Remy JM
    Blood; 2003 Feb; 101(4):1351-8. PubMed ID: 12393451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.